Loading...
XSHG
603882
Market cap1.88bUSD
Dec 05, Last price  
28.72CNY
1D
0.67%
1Q
-6.93%
IPO
161.57%
Name

Guangzhou Kingmed Diagnostics Group Co Ltd

Chart & Performance

D1W1MN
XSHG:603882 chart
P/E
P/S
1.85
EPS
Div Yield, %
3.06%
Shrs. gr., 5y
0.31%
Rev. gr., 5y
6.41%
Revenues
7.19b
-15.81%
977,201,9701,356,070,8811,837,857,6912,389,392,2213,221,579,7223,791,717,6834,525,252,8285,269,266,4978,243,763,51611,943,223,63015,476,074,5388,539,627,9017,189,544,739
Net income
-381m
L
44,085,46052,447,02931,255,951131,430,840170,035,207188,505,401233,321,406402,331,1271,509,701,8872,219,640,4452,754,787,044643,382,149-381,241,138
CFO
906m
-26.36%
88,437,50075,549,100225,966,983220,388,055292,141,284283,534,715529,623,040661,396,1591,523,107,5662,087,970,5901,947,842,7381,230,820,619906,347,521
Dividend
Jun 18, 20240.88 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Guangzhou Kingmed Diagnostics Group Co., Ltd. operates as a third-party medical laboratory company. The company offers medical diagnostic information, clinical trial, lab, food and hygiene testing, health management, medical cold chain logistics, and scientific research services, as well as vitro diagnostics, healthcare big data, artificial intelligence, and forensic testing services. It operates 37 testing laboratories in mainland of China and Hong Kong. The company was founded in 2003 and is headquartered in Guangzhou, China.
IPO date
Sep 08, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT